Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > Bio Developments

Fire ant venom to combat thick skin

19-Sep-2017 - Researchers say compounds from fire ant venom could be used to develop psoriasis treatments which limit skin-thickening side effects.

Synpromics expansion to support growing gene control business

19-Sep-2017 - Moving to a larger facility will help Scottish firm Synpromics Ltd increase its gene control and cell line services presence, the firm says.

Microtissue magic: 3D-printed tech for cell culture production 'degrades on demand'

14-Sep-2017 - Researchers at Brown University have developed a 3D printing technique which they say could be used to make cell cultures for biopharmaceutical production.

Expression yourself: Win an iPad in our bioprocessing survey

12-Sep-2017 - Is plastic fantastic? Is stainless still à la mode*? Do Chinese hamsters continue to tow the cell line? Biopharma-Reporter wants your opinions for its second annual biomanufacturing survey.

ADC update: Jazz teams with ImmunoGen, Genmab inks pact with SeaGen

30-Aug-2017 - Jazz Pharmaceuticals has become the latest firm to team with ImmunoGen in an antibody-drug conjugate (ADC) collaboration.

CSL adding scalable stem cell gene therapy tech in $91m Calimmune buy

30-Aug-2017 - CSL Behring will launch itself into the stem cell gene therapy through the acquisition of Calimmune, adding a preclinical candidate and two manufacturing efficiency technologies.

US FDA steps up enforcement against unscrupulous stem cell firms

29-Aug-2017 - The US FDA has warned a Florida-based clinic and seized vials of a smallpox vaccine in California used to create an unapproved product in a crackdown against "unscrupulous" stem cell...

Lonza expands Swiss drug product site, adds 50 jobs

25-Aug-2017 - Lonza will feed demand for its drug quality testing and formulation capabilities through an expansion at its Drug Product Services site in Basel, Switzerland.

ACF bioanalytical plant opens as cell and gene therapies reach ‘tipping point’

24-Aug-2017 - ACF Bioservices has completed the construction of its Exton, Pennsylvania, US-based facility for cell and gene product testing.

AstraZeneca ups its mRNA stake through €25m Ethris deal

22-Aug-2017 - AstraZeneca has entered a five-year collaboration to develop therapies for respiratory diseases based on Ethris’ messenger RNA (mRNA) technology.

VistaGen’s cell production methods receive US patent boost

22-Aug-2017 - VistaGen Therapeutics has received a notice of allowance for a stem cell production patent, which the firm says could be used in autoimmune disorder and cancer treatments.

Gilead ups capacity with Cali manufacturing facility

18-Aug-2017 - Biopharmaceutical firm Gilead Sciences has opened a facility in La Verne, California, US, which it says will boost manufacturing volumes.

Sanofi and Regeneron end ten-year mAb collaboration

16-Aug-2017 - “One of the most productive arrangements in the history of the biotechnology industry” will end, says Regeneron on its monoclonal antibody collaboration with Sanofi.

Artificial intelligence R&D to combat age-related diseases

11-Aug-2017 - Researchers from the University of Copenhagen and Insilico Medicine have teamed up to identify compounds for drug development, using artificial intelligence (AI). 

Reprocell grows cell and tissue-based services in Scotland

11-Aug-2017 - Human tissue-focused products and services firm Reprocell Europe has opened headquarters in Glasgow, Scotland, which it says will boost business and create jobs.

‘Origami pacman’ tech could help drug firms handle single-cells, say researchers

09-Aug-2017 - Researchers at US-based North Carolina State University and Duke University have developed a ‘microbot’ which they say could capture and transport single-cells for drug production.

Kite assesses EU manufacturing options as it submits CAR-T therapy for review

04-Aug-2017 - Kite Pharma has submitted the first CAR-T candidate axicabtagene ciloleucel to the EMA for review and says it is evaluating manufacturing options in Europe.

Horizon cell line sequence released in bid to up bioproduction efficiency

02-Aug-2017 - Horizon Discovery will allow researchers to modify a genome sequence based on its knock-out CHO K1 cell line in a bid to drive innovation in bioproduction.

Alexion ends Moderna mRNA pact

28-Jul-2017 - Alexion Pharmaceuticals says it is reducing R&D operations and terminating mRNA-focused preclinical partnerships.


Astellas cuts ADCs in California

28-Jul-2017 - Tokyo, Japan-headquartered Astellas Pharma is reducing its antibody-drug conjugate R&D activities by shutting a site in California, US.

Avantor site launches with biopharma lean

27-Jul-2017 - Avantor has opened a research centre in New Jersey, US offering gene to protein expression and drug delivery contract services.

Novartis preps production platform for alternative to Lucentis

26-Jul-2017 - Novartis has scaled up manufacturing of wet age-related macular degeneration (AMD) monoclonal antibody RTH258 ahead of a potential regulatory submission next year.

Hair-raising R&D: RepliCel developing autologous cell therapy for baldness

12-Jul-2017 - Vancouver, Canada-based RepliCel is developing an autologous cell therapy to treat patients with baldness due to androgenetic alopecia. 

Spheryx awarded Ph II grant to modify tech for biologics industry

07-Jul-2017 - Spheryx, Inc. has been awarded a $1.5m grant over two years to support modifications to the company’s propriety protein aggregation detection and monitoring technology.

News in brief

French venture fund bets on Japanese microbiome firm with €11.6 m investment

05-Jul-2017 - Seventure’s Health for Life Capital fund has announced a €11.6 million ($13.2m) financing of Tokyo-based microbiome firm Anaeropharma Science.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...